Amarin Corporation plc
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Amarin Corporation plc now
Current reporting with the operating signal separated from the noise.
Amarin Corporation plc (AMRN) Q2 2026 Earnings Call Transcript
Investors are testing whether Amarin Corporation plc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Amarin Corporation plc: Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
The story matters when it changes Amarin Corporation plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Amarin Corporation plc (NASDAQ:AMRN) Q4 2025 Earnings Call Transcript
Investors are testing whether Amarin Corporation plc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Amarin Corporation plc (AMRN) Q4 2025 Earnings Call Transcript
Investors are testing whether Amarin Corporation plc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Rick Stewart – Amarin Corporation Plc (amrn)
The story matters when it changes Amarin Corporation plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest AMRN filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Amarin Corporation plc, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →